No Data
Top-performing Hong Kong-listed stocks this week | Recent IPOs show strong momentum! Baige Online surged nearly 2.8x in its debut week, while Zhen Health Medical soared nearly 2.4x; robotics concepts heat up, with Estun rising nearly 46% on plans to acqui
This week, the Hang Seng Index rose 2.99% cumulatively to close at 23,350.03 points; the Hang Seng Tech Index gained 5.72% over the same period, closing at 4,499 points; and the Hang Seng China Enterprises Index increased 3.2% cumulatively to 7,699.76 points.
Mid-Year Review | Over 80% of Hong Kong IPOs in the First Half of the Year Ended with Gains on Debut! Sigen New Energy Surged Over 103% on Listing Day, Generating Profits Exceeding HK$33,000 per Board Lot
In the first half of 2026, the Hong Kong IPO subscription market remained highly active, and it was not uncommon to see multiple new listings debut on the same day.
Goldman Sachs Lists Recently Listed Stocks with Potential Inclusion in Southbound Trading (Table)
Goldman Sachs published a report screening newly listed Hong Kong stocks with potential inclusion in Southbound trading: MiniMax (00100.HK), Sige Energy (06656.HK), Lightelligence (01879.HK), Deseal Biotech (02526.HK), Changchun Spectrum (03277.HK), Qunhuan Technology (00068.HK), DeepAI (02723.HK), Sunmi Technology (06810.HK), Yunji (02670.HK), FS Innovation (03355.HK), Jetion Tech (07666.HK), LD Robot (01236.HK), and Yunchuanggu.
Top-performing Hong Kong stocks this week | KBT Group surged nearly 47% for the week, KBTL rose nearly 33%, amid supply disruption risks for PPE resin; newly listed Shougang Langze gained over 39%, with the CCUS leader poised to benefit from SAF market ex
This week, the Hang Seng Index declined by 0.98% cumulatively, closing at 24,718.1 points; the Hang Seng Tech Index fell by 3.75% over the same period, ending at 4,705.2 points; and the Hang Seng China Enterprises Index dropped by 0.74%, closing at 8,374.43 points.
Dano Biopharma-B (06872): Song Gaoguang has been appointed as a member of the Remuneration and Appraisal Committee.
Dano Medicine-B (06872) announced that Dr. Song Gaoguang, a non-executive director, has been appointed as a member of the Board’s Remuneration and Appraisal Committee, effective from June 8, 2026, until the expiration of the term of the first Board of Directors.
Zhito Hong Kong Stock Investment Diary | June 8
Hong Kong Stock Investment Journal | June 8, 2026